Products

SCIG Subcutaneous Immune Globulin Products

Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, SCIG is administered subcutaneously. All brands are FDA-approved to treat primary immune deficiencies and one brand is approved to treat Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). SCIG has also been used to treat other disorders.

F.D.A.-approved subcutaneous immune globulin (SCIG) products:


Product
Manufacturer
FDA-Approved Indication
SUBCUTANEOUS IMMUNE GLOBULIN (SCIG)
Product: CUTAQUIG®
Manufacturer: Octapharma
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: CUVITRU™
Manufacturer: Takeda
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAGARD LIQUID
Manufacturer: Takeda
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAKED™
Manufacturer: Takeda
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: GAMUNEX®-C
Manufacturer: Grifols
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: Hizentra®
Manufacturer: CSL Behring
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Product: HYQVIA®
Manufacturer: Takeda
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: XEMBIFY®
Manufacturer: Grifols
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Download SCIG Patient Referral Form

Contact Nufactor

At Nufactor, we are committed to providing our patients the education, support and resources necessary to complete your IVIG treatment successfully and with the desired outcomes. Please contact us with any further questions.